Login
$OBX
$12.36 +$0.00 (0.0%) After hours

$OBX SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 Form 4: Reisenauer Mark L, Director

Granted 75,364 Stock Option (Right to Buy)

13 Nov 2026 Form 3: Reisenauer Mark L, Director

No securities owned

13 Nov 2026 Form 4: Feder Julie B, Chief Financial Officer

Granted 164,790 Stock Option (Right to Buy)

13 Nov 2026 Form 4: Hari Parameswaran, Chief Medical Officer

Granted 331,173 Stock Option (Right to Buy)

13 Nov 2026 Form 4/A: Jagasia Madan, Director

Granted 678,477 Stock Option (Right to Buy)

12 Nov 2026 424B3
12 Nov 2026 10-Q
12 Nov 2026 8-K: Results of Operations and Financial Condition
05 Oct 2026 SCHEDULE 13G
09 Sep 2026 EFFECT
28 Aug 2026 S-1
14 Aug 2026 8-K/A: Financial Statements and Exhibits

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

14 Aug 2026 10-Q
11 Aug 2026 SCHEDULE 13G
10 Aug 2026 SCHEDULE 13G
10 Aug 2026 SCHEDULE 13G
10 Aug 2026 SCHEDULE 13G
05 Aug 2026 Form 4: Ross Robert W., Director

Granted 37,653 Stock Option (Right to Buy)

05 Aug 2026 Form 4: Norkunas Matthew, Director

Granted 37,653 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support